Biohaven Ltd. (BHVN:NYSE) closed at $11.43 on October 19, 2026, up 6.03% on the day. The stock trades 38.4% below its 52-week high of $18.57 and 52.8% above its 52-week low of $7.48. Over the past year, it lost 32.4%. Biohaven Ltd. is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -8.72% | -22.39% | -27.46% | -0.37% | -32.41% |
In 252 trading sessions since October 16, 2025, BHVN closed higher on 111 days (44%). Its best day was January 7, 2026 (+22.04%) and its worst was November 5, 2025 (-40.22%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 3 times.
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Find more stocks like BHVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.